Back to search

National and Kapodistrian University of Athens

Βιολογικός ρόλος της απολιποπρωτεΐνης J/Clusterin στη γήρανση και στην καρκινογένεση

Abstract

dc:description

Apolipoprotein J/Clusterin (CLU) is a highly conserved glycoprotein that has been implicated in many physiological intracellular and extracellular functions as well as in disturbance states including ageing and age-related diseases (i.e. cancer). Four main isoforms of the protein have been reported so far: the cytoplasmic (c-CLU), the secreted (s-CLU), the pre-nuclear (pn-CLU) and the nuclear (pn-CLU) protein. Translation of the primary CLU transcript results in the synthesis of c-CLU, which is further modified to the mature s-CLU that consists of two chains, a and β. The pnCLU is formed in the cytoplasm due to alternative splicing of the primary transcript and upon specific stimuli turns into the n-CLU isoform, translocates to the nucleus and forms a complex with the helicases Ku70/Ku86, leading to cell death. However, despite extensive efforts, the role of CLU in different situations has not been fully elucidated. Thus, the aim of this thesis is the study of the role of CLU isoforms in osteosarcoma (OS) cells response to different stress situations, including the development and maintenance of resistance of OS cells to chemotherapeutic agents. Initially, three OS cell lines (U-2 OS, Sa OS and KH OS) with different protein expression levels of CLU and p53 were exposed to the chemotherapeutic agent doxorubicin (DXR) for various periods of time. The cells that survived the treatment exhibited increased CLU mRNA and protein levels, while in dead cells, CLU accumulated in much higher amounts. The above-mentioned experiments revealed that the degree of CLU induction correlated negatively with the endogenous levels of expression of CLU and this was mainly the result of transcription regulation. Moreover, there seemed to exist a plateau of CLU intracellular level with regard to the protein’s cytoprotective ability and higher CLU levels exerted potential cytotoxic effects. Finally, it was shown that in cells with very low endogenous CLU amounts (KH OS), overproduction and secretion of s-CLU was necessary for the survival of the cells exposed to DXR. Our next goal was the assessment of the role of CLU proteins in different stress conditions in OS cells that over-expressed either the c-CLU or the pn-CLU isoform after stable transfection. Treatment of these cells with various concentrations of a diverse range of cytotoxic agents revealed that c-CLU/s-CLU function can be either antiapoptotic, neutral or proapoptotic, depending on its endogenous amount on a given cell line, the cellular context where it is expressed and the intensity of stress. When the populations of U-2 OS (high endogenous CLU levels) or Sa OS (medium endogenous CLU levels) c-CLU/s-CLU transfected cells were treated with agents causing genotoxic or oxidative stress, c-CLU/s-CLU accumulation had neutral effect or proapoptotic when the cells were exposed to a high concentration of the agent. On the contrary, when the populations of KH OS cells that overexpressed CLU after transfection were exposed to high levels of cytotoxic agents, higher survival rates were observed as compared to empty vector transfected cells (cytoprotective role of CLU). As far as the pn-CLU isoform is concerned, forced over-expression of pn-CLU in OS cells after stable transfection resulted neither in n-CLU production nor in cCLU/s-CLU up-regulation and the cells were viable. The fact that n-CLU was detected in some cell lines after specific treatments and not in the cells used in this or other studies, indicates that probably specific stimuli drive the production of pn-CLU or its conversion to n-CLU. Furthermore, pn-CLU or c-CLU/s-CLU forced overexpression in the cells used in this thesis had the same effect regarding the viability of the cells to cytotoxic agents. In order to study the potential role of CLU during the acquisition and maintenance of human cancer cells resistance to chemotherapeutic drugs, a series of DXR-resistant U-2 OS, Sa OS and KH OS cell lines were developed (DXR-R: RI, R2 and R3). Molecular characterization of the cell lines showed that DXR-resistance correlates with significant changes in the levels of various proteins. Only the R2 and R3 cells expressed increased protein levels of the multi-drug resistant marker MDR1, inhibition of which sensitized the cells to DXR. Consecutive analysis of the R2 cells revealed that they were not resistant only to DXR, but also to a variety of unrelated cytotoxic compounds. When a broad-spectrum characterization of the multi-drug resistant cell lines was complete, the expression levels of CLU were measured. The analysis uncovered a moderate (up to ~30%) up-regulation of CLU mRNA and c-CLU/s-CLU protein levels in the U-2 OS R2 cells, but a profound induction (~4-fold) in the KH OS R2 and R3 cells as compared to parental cells, similar to the pattern of expression of MDR1 and PARP proteins in these cell lines. So, a negative correlation between the endogenous CLU expression levels and the intensity of its up-regulation in the R2 and R3 cells was observed. The higher intracellular CLU levels were accompanied by increased extracellular amounts, but not altered subcellular localization. n-CLU was not detected in any cell line. Neutralization of the extracellular s-CLU protein or gene expression silencing via small interfering RNA (siRNA) rendered the KH OS R2 cells sensitive to apoptosis even without additional drug exposure. On the contrary, CLU depletion in the U-2 OS cell lines in the absence of DXR did not confer any further sensitization to the R2 cells as compared to the parental cells, apparently because the levels of CLU in the two U-2 OS cell lines are already too high. In conclusion, the results of this thesis reveal that CLU is a molecule which apart from functioning as an apolipoprotein or an efficient extracellular chaperone is also implicated in several intracellular activities. However, despite the diverse roles attributed to CLU, it could be just said, that the molecule confers a balance between cellular survival and death, according to environmental stimuli. The fact that the CLU mRNA and protein induction profile in R2 cells is similar to that of the MDR1 and PARP proteins, and that CLU gene down-regulation sensitizes the R2 cells to DXR, strongly suggest a direct implication of CLU in OS cells’ acquisition of the multi-drug resistance phenotype. Therefore, CLU could be used as a marker for chemoresistance in cancer cells.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Lourda, Magdalini
  • Λούρδα, Μαγδαληνή

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/18925

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Lourda, Magdalini; Λούρδα, Μαγδαληνή. Βιολογικός ρόλος της απολιποπρωτεΐνης J/Clusterin στη γήρανση και στην καρκινογένεση. National and Kapodistrian University of Athens, 2008. http://hdl.handle.net/10442/hedi/18925